TNF and diabetes mellitus: Further, our analysis with the 21 and seven genes (that link the diabetes pathway with COVID-19) suggests that TNF and INSR are key targets in COVID-19 patients with pre-existing diabetes, and the anti-TNF anti-INSR drugs may be repurposed in managing the COVID-19 severity in diabetic patients (Table 1).